Stay updated on CDX-585 in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the CDX-585 in Advanced Malignancies Clinical Trial page.

Latest updates to the CDX-585 in Advanced Malignancies Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe CDX-585 Phase 1 study record is now displayed, with its study design, eligibility criteria, outcomes, and locations. The record indicates the study is completed and no longer recruiting participants.SummaryDifference54%

- Check18 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check25 days agoChange DetectedThe ClinicalTrials.gov page now displays the Phase 1 CDX-585 study record, including its completed status, eligibility criteria, study locations, treatment plan, and outcome measures, instead of a 403 error.SummaryDifference57%

- Check32 days agoChange DetectedThe ClinicalTrials.gov error page’s footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check59 days agoChange DetectedThe study page now renders a 403 Forbidden error page, including a basic HTML structure and the 403 message, instead of the previous content. This indicates an access restriction rather than an update to substantive study details.SummaryDifference19%

Stay in the know with updates to CDX-585 in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-585 in Advanced Malignancies Clinical Trial page.